Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mazzuca Federica
Can IDO Activity Predict Primary Resistance to Anti-Pd-1 Treatment in NSCLC?
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
MA19.08 Detection of Primary Immunotherapy Resistance to PD-1 Checkpoint Inhibitors (PD1CI) in 2nd Line NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Automated Image Analysis of NSCLC Biopsies to Predict Response to Anti-Pd-L1 Therapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy
Clinical Cancer Research
Cancer Research
Oncology
Dynamic Metrics-Based Biomarkers to Predict Responders to Anti-Pd-1 Immunotherapy
British Journal of Cancer
Cancer Research
Oncology
TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-Pd-1
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.04-01 Combined Plasma cfDNA Mutations and a Serum Proteomic Signature May Identify Non-Responders to Anti PD-1 Treatment in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy
Pathology
Forensic Medicine
Pathology
P1.01-08 Hyperresponsive Disease: A New Pattern of Response in NSCLC Patients Treated by Anti-Pd-1/Pd-L1
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary